[{"Assets_0_Q2_USD":8856900000.0,"CommonStockSharesOutstanding_0_Q2_shares":365707233.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":58200000.0,"NetIncomeLoss_1_Q2_USD":35900000.0,"NetIncomeLoss_2_Q2_USD":67400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":365700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":365700000.0,"StockholdersEquity_0_Q2_USD":5265500000.0,"EarningsPerShareBasic_1_Q2_USD":0.1,"EarningsPerShareBasic_2_Q2_USD":0.18,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190813"}]